Hemagen's test pinpoints long-term HIV survivors:
This article was originally published in Clinica
Hemagen has completed the development of a new diagnostic test kit that can identify HIV patients who have an antibody that prevents them from developing full-blown AIDS. The assay could help doctors chose the best therapy for patients with the virus, sparing those who are unlikely to progress onto AIDS from unnecessary treatments. The test identifies an antibody, called anti-R7V, that appears to neutralise the HIV virus, says the Columbia, Maryland company.